Dignitana AB Publishes Q2 2024 Interim Report

REG

Advancing forward with clear vision

Financial highlights Q2 2024
  • Net Sales amounted to 21.8 MSEK (21.1), an increase of 4 percent over the same quarter in 2023.
  • Operating Result amounted to -11.0 MSEK (-4.7).
  • Net Result after financial items amounted to -11.5 MSEK (-4.7).
  • EBITDA for the second quarter were negative at -7.0 MSEK (-0.9).
  • Earnings per share were -0.14 SEK (-0.07).
  • Cash Balance amounted to 7.0 MSEK (5.4).
  • Average Daily Treatment Revenue (ADTR)* was 223 TSEK (241) in the quarter.
Business highlights during the period
  • Dignitana Rights Issue was fully subscribed at 19.1 MSEK before issue cost.
  • In May Dignitana published the Annual Report for 2023.
  • Dignitana’s Annual General Meeting was held on 23 May 2024, electing Fredrik Lindgren and Dr. Hope Rugo as new Directors.
  • Fredrik Jonsson was appointed as CEO beginning 1 May 2024 following the resignation of Catarina Löwenadler.
  • Dignitana Board Member William Cronin resigned.
Business highlights after the period
  • Dignitana signed a multi-year Distribution Agreement for Konica Minolta to be the exclusive provider of The DigniCap Scalp Cooling System in Japan.
  • Dignitana participated in the Annual Congress of the Oncology Nursing Society in Washington, D.C.

Key Figures
DIGNITANA GROUP Q2 2024 Q2 2023 Q1-Q2 2024 Q1-Q2 2023 Full Year 2023
Net sales, TSEK 21,844 21,089 43,009 42,578 86,063
Total revenues, TSEK 22,046 23,159 43,334 44,764 89,025
Net profit after financial items, TSEK -11,454 -4,662 -16,510  -8,600 -17,228
Cash and bank balances, TSEK 6,977 5,423 6,977 5,423 6,027
Earnings per share before and after dilution, SEK -0.14 -0.07 -0.22 -0.12 -0.25
Average Daily Treatment revenue*, TSEK 223 241 232 242 239

*ADTR includes pay-per-treatment revenue from patients and facilities in the U.S. Does not include lease revenue or disposable sales.

All financial reports are available at www.dignitana.com/investor-relations/financial-reports/

This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 22-08-2024 08:00 CET.

Datum 2024-08-22, kl 08:00
Källa Cision
Bifogade filer
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!